I-Mab to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference

Core Points - I-Mab, a U.S.-based global biotech company, focuses on developing precision immuno-oncology agents for cancer treatment [2] - The management team of I-Mab will participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference on February 11-12, 2025 [1] - The conference will include a company presentation and one-on-one meetings, with I-Mab's presentation scheduled for February 11, 2025, from 4:00 to 4:30 PM ET [1] Company Overview - I-Mab is headquartered in Rockville, Maryland, and has operations in Short Hills, New Jersey [2] - The company specializes in precision immuno-oncology, targeting cancer treatment [2] Contact Information - Investor and media inquiries can be directed to PJ Kelleher at LifeSci Advisors [3] - Contact details include a phone number and email for investor relations [3]